Trial · NCT07882992
Acceptance-based Self-care Intervention for Older Adults With Multimorbidity
NCT07882992, Not applicable, Not yet recruiting, Chinese University of Hong Kong
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Acceptance-based Self-care Intervention for Older Adults With Multimorbidity. Trials, record NCT07882992. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07882992
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Acceptance-based Self-care Intervention for Older Adults With Multimorbidity
- NCT number
- NCT07882992
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 306 participants, estimated
- Lead sponsor
- Chinese University of Hong Kong
- Conditions
- Older Adults (60 - 85 Years Old), Self-care, Multimorbidity
- Interventions
- Acceptance-based activities, Self-care activities
- First posted
- 2026-10-20
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Self-care behaviors | Baseline, 3 month, 6 month, and 9 month | Assessed using the Chinese version of the Self-rated Abilities for Health Practices (SRAHP). The SRAHP comprises 28 items evaluating nutrition, exercise, psychological well-being, and responsible health practices, rated on a 5-point Likert scale (0 = not confident; 4 = very confident), ranging from 0 to 112. . A higher score indicate a better self-care behavior. |
| Secondary | Treatment burden | Baseline, 3 month, 6 month, and 9 month | The Chinese version of the Multimorbidity Treatment Burden Questionnaire (MTBQ) consists of 12 items rated on a 5-point Likert scale, with weighted scores ranging from 0 to 100. The scores are categorized into four levels: no burden (score = 0), low burden (score \< 10), medium burden (score 10-21), and high burden (score ≥ 22). |
| Secondary | Physical functioning | Baseline, 3 month, 6 month, and 9 month | The Short Performance Physical Battery is a reliable and objective assessment for assessing older adults' physical function. It consists of three tests, i.e., chair stand, balance, and gait speed. The total score ranges from 0-12, with high scores indicating better physical function. |
| Secondary | Psychological flexibility | Baseline, 3 month, 6 month, and 9 month | Measured by the Chinese simplified psychological flexibility scale-6. It consists of 6 items rated on 5-point Likert scale. The total score ranges from 6-30, with high scores indicating better psychological flexibility. |
| Secondary | Depressive symptoms | Baseline, 3 month, 6 month, and 9 month | Measured by the Chinese version of the Geriatric Depression Scale-15. The scale has 15 dichotomous items (score 0 or 1), with high scores indicating more depressive symptoms. |
| Secondary | Health-related quality of life | Baseline, 3 month, 6 month, and 9 month | The Chinese version of the 36-Item Short Form Health Survey (SF-36) will be used, which has 36 items that covers eight domains, with weighted scores ranging from 0 to 100. High scores indicating better health-related quality of life. |
| Secondary | Unscheduled healthcare use | Baseline, 3 month, 6 month, and 9 month | Measured by the number of unscheduled visits to general practitioner clinics and emergency departments, in-patient admissions, and the total length of in-hospital stay over the previous three months. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07882992
GET https://conductscience.org/api/trials/v1/NCT07882992/registered